• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ABIOMED, Inc. - Common Stock (NQ: ABMD )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 381.35 (2)
    Ask (Size) 382.97 (10)
    Prev. Close 381.02
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 45,091,184
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Risk Vs Reward Vs Folly: Navigating Investment Choices
    During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of... 
    Via Talk Markets
    Is It Too Late to Buy Johnson & Johnson's Stock?
    This healthcare juggernaut's recent quarterly results prove just how strong its business is. 
    Via The Motley Fool

    Performance

    More News

    Read More
    2 Best Buffett Stocks to Buy for the Long Haul
    Via The Motley Fool
    FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial
    From Abiomed, Inc.
    Via Business Wire
    If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today
    Via Benzinga
    Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years
    Via Benzinga
    Will Investors Notice Exciting Sign On Abiomed's Chart?
    Via Benzinga
    Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
    Via The Motley Fool
    The Best Stocks to Invest $20,000 in Right Now
    Via The Motley Fool
    Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
    Via The Motley Fool
    Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
    Via Benzinga
    2 Top Dividend Kings to Buy for the Long Haul
    Via The Motley Fool
    Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
    Via MarketBeat
    This Monster Dividend Stock Isn't Done Growing
    Via The Motley Fool
    Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
    Via Investor's Business Daily
    First Patients in the World Treated with Impella RP Flex with SmartAssist
    From Abiomed, Inc.
    Via Business Wire
    3 Healthcare Stocks to Buy and Hold for the Next 10 Years
    Via The Motley Fool
    Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
    Via Benzinga
    Bear Market Blues? 3 of the Best Stocks to Own in 2023
    Via The Motley Fool
    Peering Into Abiomed's Recent Short Interest
    Via Benzinga
    ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD
    From Kahn Swick & Foti, LLC
    Via Business Wire
    S&P 500 Component DexCom Set For Further Price, Earnings Growth
    Via MarketBeat
    Topics Stocks
    Exposures US Equities
    2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield
    Via The Motley Fool
    Better Buy: Johnson & Johnson vs. Abbott Laboratories
    Via The Motley Fool
    Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
    Via The Motley Fool
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.